Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney…
NCT00003342 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003342 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer |
| Official title | Phase I Trial of Dose-Dense Gemcitabine, Doxorubicin, Then Paclitaxel Plus Carboplatin In Patients With Transitional Cell Carcinoma of the Urothelium and Impaired Renal Function |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, carboplatin, doxorubicin hydrochloride, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 30 |
| Start date | Dec 1, 1997 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: